Advertisement

Legal & Regulatory Issues

Advertisement

Denmark-based Novo Nordisk filed multiple lawsuits June 20 against spas and clinics across four states that allegedly marketed and sold unapproved compounded versions of the drugmaker's popular Ozempic and Wegovy products. 

Advertisement